Finch Therapeutics Group
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
200 Innerbelt Rd Ste 400, Somerville, Ma...Phone Number
(617) 229-6499Website
www.finchtherapeutics.comRevenue
<$5 MillionIndustry
About Finch Therapeutics Group
Finch Therapeutics is an early pioneer in the field of microbiome therapeutics, boasting a leading portfolio of innovative microbiome assets applicable to various product strategies and therapeutic areas. The company focuses on leveraging insights from human microbiota transplantation studies to develop its microbiome assets. Recently, Finch announced the discontinuation of its Phase 3 trial of CP101 in recurrent C. difficile, shifting its focus towards maximizing the value of its intellectual property estate and other assets. Finch aims to explore partnerships and collaborations to further advance its portfolio in the microbiome therapeutics space.Explore more
Finch Therapeutics Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Finch Therapeutics Group
Compare insights from companies similar to Finch Therapeutics Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Finch Therapeutics Group Tech Stack
A closer look at the technologies used by Finch Therapeutics Group
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Finch Therapeutics Group
Sign Up For FreeTo access detailed company insights
Finch Therapeutics is an early pioneer in the field of microbiome therapeutics, boasting a leading portfolio of innovative microbiome assets applicable to various product strategies and therapeutic areas. The company focuses on leveraging insights from human microbiota transplantation studies to develop its microbiome assets. Recently, Finch announ... Read More
